We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+6.46%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$81.2B
AUM Growth
+$4.94B
(+6.5%)
Cap. Flow
-$6.14B
Cap. Flow
% of AUM
-7.55%
Top 10 Holdings %
Top 10 Hldgs %
23.23%
Holding
2,627
New
307
Increased
786
Reduced
648
Closed
292
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelon
EXC
|
+$410M |
| 2 |
American Electric Power
AEP
|
+$309M |
| 3 |
UnitedHealth
UNH
|
+$239M |
| 4 |
Johnson & Johnson
JNJ
|
+$235M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$330M |
| 2 |
Consolidated Edison
ED
|
+$330M |
| 3 |
PNC Financial Services
PNC
|
+$284M |
| 4 |
Salesforce
CRM
|
+$173M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.56% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 13.3% |
| 4 | Industrials | 12.02% |
| 5 | Consumer Discretionary | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Bristol-Myers Squibb
BMY
$133B
| $64.1M | 0.08% |
1,001,905
+62,108
| +7% | +$4.16M |
|
|
AZPN
152
DELISTED
Aspen Technology Inc
AZPN
| $63.7M | 0.08% |
379,806
-17,358
| -4% | -$3.22M |
|
153
HCA Healthcare
HCA
$87.2B
| $62.4M | 0.08% |
205,749
+3,619
| +2% | +$1.01M |
|
154
Adams Diversified Equity Fund
ADX
$3.13B
| $61.9M | 0.08% |
3,684,767
| – | – |
|
155
KT
KT
$8.62B
| $60.3M | 0.07% |
5,338,379
+3,326,251
| +165% | +$38.8M |
|
156
Charter Communications
CHTR
$17.3B
| $59.9M | 0.07% |
163,151
-23,504
| -13% | -$8.02M |
|
157
Teradyne
TER
$57.6B
| $59.4M | 0.07% |
533,452
-44,144
| -8% | -$4.43M |
|
158
Micron Technology
MU
$930B
| $56.7M | 0.07% |
898,969
-43,222
| -5% | -$2.78M |
|
159
Coca-Cola Femsa
KOF
$22.7B
| $55M | 0.07% |
660,581
-10,773
| -2% | -$923K |
|
|
GAM
160
General American Investors Company
GAM
$1.56B
| $54.8M | 0.07% |
1,314,303
| – | – |
|
161
Trip.com Group
TCOM
$29.6B
| $54M | 0.07% |
1,542,589
+466,788
| +43% | +$16.2M |
|
162
Equinix
EQIX
$101B
| $52.7M | 0.06% |
67,206
-4,361
| -6% | -$3.19M |
|
|
SPLK
163
DELISTED
Splunk Inc
SPLK
| $51M | 0.06% |
481,107
+70,202
| +17% | +$6.67M |
|
164
Middleby
MIDD
$6.04B
| $50.9M | 0.06% |
344,333
+64,132
| +23% | +$9.04M |
|
165
Shinhan Financial Group
SHG
$32.8B
| $49.9M | 0.06% |
1,914,904
+838,265
| +78% | +$22.3M |
|
166
Jacobs Solutions
J
$15.9B
| $49.6M | 0.06% |
504,778
+353,055
| +233% | +$33.7M |
|
167
Booking.com
BKNG
$149B
| $48.6M | 0.06% |
450,250
+15,425
| +4% | +$1.63M |
|
168
JPMorgan Chase
JPM
$935B
| $48.5M | 0.06% |
333,257
-4,219
| -1% | -$580K |
|
169
Mercado Libre
MELI
$95.2B
| $48M | 0.06% |
40,499
+5,390
| +15% | +$6.78M |
|
|
CAF
170
Morgan Stanley China A Share Fund
CAF
$322M
| $44.8M | 0.06% |
3,528,272
-4,846
| -0.1% | -$65.1K |
|
171
Edwards Lifesciences
EW
$49.6B
| $44.6M | 0.05% |
472,312
+366,597
| +347% | +$31.9M |
|
172
Elevance Health
ELV
$81.5B
| $43.7M | 0.05% |
98,462
-987
| -1% | -$455K |
|
|
BLD
173
DELISTED
TopBuild
BLD
| $43.7M | 0.05% |
164,190
+29,859
| +22% | +$6.57M |
|
174
Lowe's Companies
LOW
$117B
| $43.7M | 0.05% |
193,519
-7,202
| -4% | -$1.5M |
|
175
Diageo
DEO
$49B
| $43.7M | 0.05% |
251,681
+100,977
| +67% | +$18M |
|
Similar funds
QCM
Lazard Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Lazard Asset Management held 2,627 positions worth $81.2B, up 6.5% from $76.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $6.14B in Q2 2023, closing 292 positions and reducing 648 holdings. Its most notable exit was ABB Ltd, an estimated $107M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Nice worth $14.7M.
- Lazard Asset Management's largest Q2 2023 buy was Nice: 71,266 shares worth $14.7M.
- Lazard Asset Management added most to Exelon in Q2 2023, an estimated $410M increase.
- Lazard Asset Management's biggest Q2 2023 reduction was Dollar General, cutting an estimated $330M.
- Lazard Asset Management fully exited ABB Ltd in Q2 2023, selling an estimated $107M.
- Lazard Asset Management's ten largest holdings make up 23% of its $81.2B portfolio in Q2 2023.
- Lazard Asset Management opened 307 new positions and closed 292 in Q2 2023.
- Lazard Asset Management's portfolio value rose 6.5% quarter-over-quarter to $81.2B.
Based on Lazard Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.